Adjuvant immunotherapy of dendritic cells and cytokine-induced killer cells is safe and enhances chemotherapy efficacy for multiple myeloma in China: a meta-analysis of clinical trials.
about
Adjuvant immunotherapy of dendritic cells and cytokine-induced killer cells is safe and enhances chemotherapy efficacy for multiple myeloma in China: a meta-analysis of clinical trials.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Adjuvant immunotherapy of dend ...... a-analysis of clinical trials.
@en
Adjuvant immunotherapy of dend ...... a-analysis of clinical trials.
@nl
type
label
Adjuvant immunotherapy of dend ...... a-analysis of clinical trials.
@en
Adjuvant immunotherapy of dend ...... a-analysis of clinical trials.
@nl
prefLabel
Adjuvant immunotherapy of dend ...... a-analysis of clinical trials.
@en
Adjuvant immunotherapy of dend ...... a-analysis of clinical trials.
@nl
P2093
P2860
P356
P1476
Adjuvant immunotherapy of dend ...... a-analysis of clinical trials.
@en
P2093
P2860
P304
P356
10.2147/DDDT.S146959
P407
P577
2017-11-15T00:00:00Z